Inventor

Giorgio Trinchieri

Inventor
Wynnewood, PA, US

Overview

20→
Patents
1995–2016
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
C07KPeptides29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
Y02ATechnologies for adaptation to climate change10%
C12NMicroorganisms or enzymes7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
9,475,839'Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling'20167,122,633'Natural killer stimulatory factor'20066,875,580'Antibodies specific for plasmacytoid dendritic cells'20056,555,658'Antibodies to natural killer stimulatory factor'20036,375,944'Methods and compositions for enhancing the immunostimulatory effect of interleukin-12'20026,372,208'Method of reducing an immune response to a recombinant virus'20026,300,478'Antibodies to natural killer stimulatory factor'20016,251,957'Method of reducing an immune response to a recombinant virus'20016,168,923'Compositions and methods for use of IL-12 as an adjuvant'20016,086,876'Methods and compositions for the inhibition of interleukin-12 production'20005,976,539'Compositions and methods for use of IL-12 as an adjuvant'19995,872,154'Method of reducing an immune response to a recombinant adenovirus'19995,811,523'Antibodies to natural killer stimulatory factor'19985,723,127'Compositions and methods for use of IL-12 as an adjuvant'19985,688,690'Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto'19975,648,467'Natural killer cell stimulatory factor'19975,648,072'Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor'19975,571,515'Compositions and methods for use of IL-12 as an adjuvant'19965,569,454'Methods of treating infection using natural killer stimulatory factor'19965,457,038'Natural killer stimulatory factor'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2001Patents assigned to GENETICS INST (5)· patent assignee history
1995–2006Based in Wynnewood, PA, US· patent location history
1996–2003Patents assigned to WISTAR INST (9)· patent assignee history
1996–2002Patents assigned to UNIV PENNSYLVANIA (8)· patent assignee history
2002–2005Based in Charly, FR· patent location history
2003–2006Patents assigned to WYETH CORP (2)· patent assignee history
2016Patents assigned to CARDONE MARCO A (1)· patent assignee history
2016Based in Potomac, MD, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WISTAR INST91996–2003
UNIV PENNSYLVANIA81996–2002
GENETICS INST51995–2001
WYETH CORP22003–2006
CARDONE MARCO A12016
Locations
LocationPatentsSpan
Wynnewood, Pennsylvania, US171995–2006
Charly, FR22002–2005
Potomac, Maryland, US12016